Curiosis (494120.KQ) stock: key figures, P/E, revenue and dividend

Health Care · South Korea · ISIN KR7494120009

Price
9,120.00 KRW
Market cap
139.17 bn KRW
P/E (2025)
–
P/S (2025)
19.06
Dividend yield
0.00 %
Net margin
-107.69 %
Return on equity (ROE)
-27.89 %
Return on assets (ROA)
-22.98 %

Curiosis financials

Fiscal year20242025
Revenue5.41 bn KRW7.30 bn KRW
Gross profit2.21 bn KRW3.49 bn KRW
Operating income-6.20 bn KRW-7.53 bn KRW
EBIT-3.25 bn KRW-7.61 bn KRW
Net income-4.82 bn KRW-7.86 bn KRW
Diluted EPS – continuing operations-756.29 KRW-1,033.95 KRW

Full history since 2024, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Curiosis

Curiosis, Inc. develops, produces, and supplies laboratory equipment in the field of life science. It offers cell imaging, cell counting, cell isolation, and digital pathology products. The company was incorporated in 2015 and is based in Seoul, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.